Shohls Solution

Drug Overview

Maintaining the delicate acid-base balance of the body is a fundamental necessity in nephrology and urological care. Within the specialized Drug Category of Urology, Shohls Solution serves as a foundational therapy for patients struggling with metabolic and chemical imbalances. This medication belongs to the Drug Class known as Urinary Alkalinizers.

Shohl’s Solution is a systemic alkalinizing agent that provides a dual-buffer system to neutralize excess acid in the bloodstream and urine. By converting into bicarbonate within the body, it helps preserve renal function and prevents the long-term complications associated with chronic acidity.

• Generic Name: Sodium Citrate and Citric Acid
• US Brand Names: Bicitra, Oracit, Cytra-2
• Route of Administration: Oral (Liquid solution)
• FDA Approval Status: Fully FDA-approved for the treatment of metabolic acidosis and for the prevention of specific types of kidney stones.

What Is It and How Does It Work? (Mechanism of Action)

To understand how Shohl’s Solution functions, one must look at the way the kidneys manage waste. Normally, the kidneys filter out excess acid to keep the blood pH stable. However, in conditions like chronic kidney disease (CKD) or certain urological disorders, the body produces more acid than it can remove, leading to a dangerous state called metabolic acidosis.

Shohl’s Solution works through a specialized physiological process called Metabolic Alkalization. The solution contains sodium citrate and citric acid. At the molecular level, once the solution is ingested and absorbed into the bloodstream, the citrate ions are transported to the liver. Here, they undergo oxidation—a metabolic “burning” process—that converts each citrate molecule into three molecules of bicarbonate.

Bicarbonate is the body’s primary natural buffer. Physiologically, this increase in bicarbonate neutralizes hydrogen ions (acid) in the blood, raising the systemic pH back toward a healthy, neutral range. Furthermore, as the excess bicarbonate is eventually filtered by the kidneys and excreted into the urinary tract, it raises the pH of the urine as well. This Urinary Alkalinization makes the urine less acidic, which is critical for dissolving certain minerals and preventing the formation of uric acid and cystine stones. Unlike some other medications, Shohl’s Solution is highly palatable and easily absorbed, making it an efficient tool for long-term metabolic correction.

FDA-Approved Clinical Indications

Primary Indication

• Metabolic Acidosis: Shohl’s Solution is primarily FDA-approved for the long-term management of metabolic acidosis, particularly in patients with chronic renal insufficiency or Renal Tubular Acidosis (RTA). It helps prevent bone loss and muscle wasting caused by chronic acidity.

Other Approved & Off-Label Uses

Urologists and nephrologists utilize the neutralizing power of this solution for several critical pelvic and renal conditions:

• Primary Urology Indications:
  • Uric Acid Stone Dissolution: Used to raise urinary pH to a range where uric acid stones become soluble and can physically dissolve without surgery.
  • Prevention of Calcium Oxalate Stones: By increasing urinary citrate levels, it acts as a crystal inhibitor, preventing calcium from clumping into stones.
  • Cystinuria Management: Employed to maintain a highly alkaline urine (pH above 7.5) to keep cystine minerals dissolved.
  • Pre-Anesthetic Gastric Neutralization: Used off-label in surgical settings to neutralize stomach acid before procedures, reducing the risk of lung injury if aspiration occurs.
• Uro-oncological Support:
  • Chemotherapy Protection: Used to prevent “Urate Nephropathy” in patients undergoing aggressive treatment for certain cancers, where the rapid breakdown of cells causes a dangerous spike in acid levels.

Dosage and Administration Protocols

Dosing for Shohl’s Solution is highly individualized based on the patient’s blood bicarbonate levels and urinary pH goals. It is a liquid medication that should be diluted with water and taken after meals to prevent stomach upset.

Specific Administration Protocols:

• Dilution: The solution should be mixed with 1 to 3 ounces of water or juice and chilled to improve the taste.
• Renal Insufficiency: In patients with advanced renal failure (low CrCl/GFR), sodium intake must be monitored. For those requiring a sodium-restricted diet, a potassium-based alkalinizer (like Polycitra) may be preferred over Shohl’s Solution.
• Geriatric Patients: Older adults should start at the lower end of the dosing spectrum and undergo frequent electrolyte monitoring.

“Dosage must be individualized by a qualified healthcare professional.”

Clinical Efficacy and Research Results

Clinical efficacy data from 2020–2026 confirms that Shohl’s Solution remains a gold standard for stabilizing renal chemistry. In longitudinal studies of patients with chronic kidney disease, consistent use of sodium citrate was shown to significantly slow the decline of the Glomerular Filtration Rate (GFR).

• Bicarbonate Levels: Precise numerical data from clinical trials shows that a standard dose of 30 mL can increase serum bicarbonate by 2 to 4 mEq/L within several days of initiation.
• Urinary pH: In urological studies, Shohl’s Solution consistently raises urinary pH from a baseline of 5.5 to a target range of 6.5 to 7.0, which is the optimal environment for stone prevention.
• Oncology Data: While not a Targeted Therapy or Immunotherapy, Shohl’s Solution provides essential supportive care. In patients undergoing treatment with a Monoclonal Antibody or those tracking a PSA nadir, maintaining a neutral pH prevents the “acid-stress” that can complicate renal filtration during cancer recovery. It does not negatively impact Progression-Free Survival (PFS) metrics but ensures the kidneys are healthy enough to withstand systemic treatments.

Safety Profile and Side Effects

Black Box Warning: There is currently NO Black Box Warning for Shohl’s Solution. However, it is contraindicated in patients with severe sodium restriction or heart failure.

Common Side Effects (>10%)

• Gastrointestinal Distress: Diarrhea, nausea, and stomach cramping, particularly if not diluted properly.
• Laxative Effect: Due to the salt concentration, some patients experience frequent loose stools.
• Fluid Retention: The sodium content can lead to mild swelling in the ankles or feet.

Serious Adverse Events

• Metabolic Alkalosis: Over-treatment can cause the blood to become too alkaline, leading to confusion or muscle twitching.
• Hypernatremia: Excessive sodium levels in the blood, which can be dangerous for patients with high blood pressure.
• Acute Kidney Injury: If used in patients with an absolute urinary obstruction without proper drainage.
• Cardiovascular Overload: Excess sodium can exacerbate heart failure or pulmonary edema.

Management Strategies

Gastrointestinal side effects are best managed by taking the solution exactly 30 minutes after a meal and ensuring it is served chilled. Patients with high blood pressure must have their blood pressure and electrolytes monitored every 2 to 4 weeks during the initiation phase.

Research Areas

Current research into Shohl’s Solution is exploring “Targeted Tissue Delivery” and its potential role in enhancing the recovery phase of Robotic-Assisted Surgery. By maintaining a stable pH post-operatively, researchers believe they can reduce the incidence of catheter-associated mineral crusting.

Additionally, medical authorities are investigating “Long-acting injectable formulations” of alkalinizing agents for patients with severe malabsorption syndromes. There is also active interest in how urinary pH affects the efficacy of Immunotherapy in bladder cancer; research suggests that a more neutral environment may improve the localized immune response to certain intravesical treatments. While not yet a part of Gene Therapy for Bladder Cancer, metabolic stabilization remains a cornerstone of the holistic urological protocol.

Disclaimer: The research discussed regarding Shohl’s Solution is currently exploratory in nature and remains in early investigative or theoretical stages. These findings are not yet validated for routine clinical application and are not applicable to established medical practice or professional treatment protocols. 

Patient Management and Clinical Protocols

Pre-treatment Assessment

• Baseline Diagnostics: Serum electrolytes (Sodium, Potassium, Chloride, Bicarbonate), Urinalysis, and urinary pH. Prostate-Specific Antigen (PSA) for age-appropriate men.
• Organ Function: Evaluation of Renal function (BUN/Creatinine/GFR) is mandatory.
• Specialized Testing: Digital Rectal Exam (DRE) for general screening and a 24-hour urine collection to assess stone risk.
• Screening: Cardiovascular health assessment, particularly for patients with a history of edema or heart failure.

Monitoring and Precautions

• Vigilance: Monitoring for “Alkali-Loss” in patients with chronic diarrhea.
• Lifestyle Recommendations:
  • Fluid Management: Timed voiding and ensuring high water intake (at least 2.5 liters daily).
  • Pelvic Floor Exercises (Kegels): These help maintain general pelvic health and stability.
  • Dietary Triggers: Reduction in high-salt foods and avoidance of excessive protein, which creates more acid.
  • Smoking Cessation: Essential for preserving long-term kidney and bladder health.

“Do’s and Don’ts” list

• DO dilute the solution with water or juice before drinking.
• DO take the medication after meals to protect your stomach.
• DO chill the solution in the refrigerator to make the taste more pleasant.
• DON’T use Shohl’s Solution if you are on a very strict low-salt diet for heart disease.
• DON’T take aluminum-based antacids at the same time, as citrate can increase aluminum absorption.
• DON’T skip doses; maintaining a steady pH is essential for preventing stone growth.

Legal Disclaimer

The information provided in this guide is for informational purposes only and does not replace professional medical advice from a qualified healthcare provider. This content is intended for patients and healthcare professionals in the US and European markets. Always consult with a urologist or nephrologist before beginning any metabolic or alkalinizing therapy. Results may vary depending on the severity of the underlying condition.